[ET Net News Agency, 27 March 2024] CARDIOFLOW-B (02160) rose 16.2% to HK$1.22,
breaking above the 10-D SMA of HK$1.171.
It hits an intra-day high of HK$1.23, and an intra-day low of HK$1.05. The total shares
traded was 4.14 million, with a value of HK$4.63m. The active buy/sell ratio is 69:31,
with net buying turnover of HK$1.74m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net
responsive buying turnover of HK$436,416, with volume weighted average price of HK$1.105.
CHINA INV INFO accounts for greatest net responsive selling turnover of HK$438,892, with
volume weighted average price of HK$1.145.
Basic Information
=================
---------------------------------
Nominal 1.220 % Chg +16.19%
High 1.230 Low 1.050
Shares Tr 4.14m Turnover 4.63m
10-D SMA 1.171 %H.V 52.437
20-D SMA 1.222 VWAP 1.118
50-D SMA 1.275 RSI14 48.883
---------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 69:31, with net buying
turnover of HK$1.74m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
CARDIOFLOW-B (02160) 1.22 +16.19
GENSCRIPT BIO (01548) 14.20 -1.93
INNOVENT BIO (01801) 38.25 -0.78
JXR (01951) 2.37 -1.25
EVEREST MED-B (01952) 22.20 +3.02
WUXI BIO (02269) 13.70 +1.03
WUXI APPTEC (02359) 37.10 -2.62
BEIGENE (06160) 92.25 -1.49
ZAI LAB (09688) 12.40 -1.12
AKESO (09926) 46.20 -1.60
---------------------------------------------
(ed)